Abstract：
BACKGROUND: Many minimally invasive techniques have been developed over the years to treat primary ventral hernias and rectus abdominis diastasis, all of which have their advantages and disadvantages in terms of complications, reproducibility, and cost. We present a case-series of a novel approach that was safe and reproducible in a cohort of 17 patients.
METHODS: All patients in the study underwent the novel procedure between October 2022 and July 2023. We collected data retrospectively, including patient general characteristics, surgical outcomes, and complications. Patient follow-up lasted 12 months to exclude recurrences.
RESULTS: Seventeen patients underwent the procedure for primary uncomplicated ventral hernias and rectus diastasis. The median length of hospital stay was 2 days (IQR 2-3). In 4 out of 17 cases minor complications occurred within 30 days, of which 3 were class I and 1 was a class II complication according to the Clavien-Dindo classification. There were no recurrences.
CONCLUSIONS: Although limited by a small cohort of patients and a non-comparative study design, our study presents encouraging results in regards to the safety of this technique. More studies with a larger study population are needed to evaluate the benefits and pitfalls of this new technique.[query names].
METHODS: All patients in the study underwent the novel procedure between October 2022 and July 2023. We collected data retrospectively, including patient general characteristics, surgical outcomes, and complications. Patient follow-up lasted 12 months to exclude recurrences.
RESULTS: Seventeen patients underwent the procedure for primary uncomplicated ventral hernias and rectus diastasis. The median length of hospital stay was 2 days (IQR 2-3). In 4 out of 17 cases minor complications occurred within 30 days, of which 3 were class I and 1 was a class II complication according to the Clavien-Dindo classification. There were no recurrences.
CONCLUSIONS: Although limited by a small cohort of patients and a non-comparative study design, our study presents encouraging results in regards to the safety of this technique. More studies with a larger study population are needed to evaluate the benefits and pitfalls of this new technique.[query names].
摘要：
背景：多年来，已经开发了许多微创技术来治疗原发性腹侧疝和腹直肌分离症，所有这些在并发症方面都有其优点和缺点，再现性，和成本。我们在17名患者的队列中提出了一系列安全且可重复的新方法。
方法：研究中的所有患者在2022年10月至2023年7月期间接受了新手术。我们回顾性地收集了数据，包括患者的一般特征，手术结果,和并发症。患者随访持续12个月以排除复发。
结果：17例患者接受了原发性无并发症腹侧疝和直肌舒张的手术。中位住院时间为2天（IQR2-3）。17例中有4例在30天内发生轻微并发症，根据Clavien-Dindo分类，其中3例为I类，1例为II类并发症。没有复发。
结论：尽管受一小部分患者和非比较研究设计的限制，我们的研究在这项技术的安全性方面取得了令人鼓舞的结果.需要更多的研究人群来评估这种新技术的好处和陷阱。[查询名称]。
方法：研究中的所有患者在2022年10月至2023年7月期间接受了新手术。我们回顾性地收集了数据，包括患者的一般特征，手术结果,和并发症。患者随访持续12个月以排除复发。
结果：17例患者接受了原发性无并发症腹侧疝和直肌舒张的手术。中位住院时间为2天（IQR2-3）。17例中有4例在30天内发生轻微并发症，根据Clavien-Dindo分类，其中3例为I类，1例为II类并发症。没有复发。
结论：尽管受一小部分患者和非比较研究设计的限制，我们的研究在这项技术的安全性方面取得了令人鼓舞的结果.需要更多的研究人群来评估这种新技术的好处和陷阱。[查询名称]。
